BIOSPAIN Congress (26-28th September 2023)

Inhibitec’ s team had the privilege to participate in BIOSPAIN 2023, one of the main international biotechnology events in southern Europe, held in Barcelona. This was a dynamic conference marked by numerous meetings we had which offered the great opportunity to share our innovative therapy for Psoriatic Arthritis with potential investors and collaborators.

This platform allowed us to present our business project vision to some of the most relevant leaders in the healthcare and biotechnology sectors and proof our total commitment with the patients. The conversations were productive, and we are deeply grateful for the interest and support we received.

Share the Post:

Related Posts

Inhibitec has received funding ((€3,533.45) through the Planes de Promoción Comercial program (NM25-PC-109), supported by Sociedad para el Desarrollo Regional de Cantabria (SODERCAN). This grant...

Inhibitec Antibodies has been selected for the ‘Programa Personal Técnico I+D’, supported by Sociedad para el Desarrollo Regional de Cantabria (SODERCAN), enabling us to expand...

Inhibitec Antibodies has been one of the startups selected in the ‘Programa Personal Tecnico I+D’ supported by Sociedad para el Desarrollo Regional de Cantabria (SODERCAN)...

Scroll to Top